AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10023787 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg/d for 1 week, then tapered over 3 weeks)
Number of subjects: 40
Study 10023787 — intervention group
Group type: COMPARATOR
Intervention: Control (saline placebo)
Number of subjects: 40
Study 10023787 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 40
Study 10023787 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 8588068 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton (5-lipoxygenase inhibitor)
Number of subjects: 0
Study 8588068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2216227 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bupivacaine hydrochloride on both fallopian tubes
Number of subjects: 64
Study 2216227 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bupivacaine hydrochloride on the right fallopian tube only
Number of subjects: 64
Study 2216227 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bupivacaine hydrochloride on the left fallopian tube only
Number of subjects: 64
Study 2216227 — intervention group
Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 64
Study 342438 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 40
Study 342438 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 40
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting activity of An. gambiae s.l. outdoors
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting activity of An. funestus s.l. outdoors
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting activity of An. funestus s.l. indoors
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting activity of An. gambiae s.l. during wet season
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting location preference of An. gambiae s.l.
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting location preference of An. funestus s.l. during wet season
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biting location preference of An. funestus s.l. during dry season
Number of subjects: 12
Study 31194960 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection from malaria vectors by LLINs
Number of subjects: 12
Study 28785809 — intervention group
Group type: EXPERIMENTAL
Intervention: Mud-bath therapy (MBT) group: daily treated with a combination of local mud-packs at 42 °C and baths in mineral water at 37 °C for 15 min, for 12 applications over a period of 2 weeks, in addition to standard therapy.
Number of subjects: 32
Study 28785809 — intervention group
Group type: COMPARATOR
Intervention: Control group: continued their conventional treatment alone.
Number of subjects: 32
Study 25874654 — intervention group
Group type: EXPERIMENTAL
Intervention: Public sector costs
Number of subjects: 438
Study 25874654 — intervention group
Group type: EXPERIMENTAL
Intervention: National cash-for-care allowance
Number of subjects: 438
Study 25874654 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug prescriptions
Number of subjects: 438
Study 25874654 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure for private care workers
Number of subjects: 438
Study 25874654 — intervention group
Group type: EXPERIMENTAL
Intervention: Value of informal care
Number of subjects: 438
Study 25874654 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic factors
Number of subjects: 438
Study 24132057 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light + melatonin capsule
Number of subjects: 0
Study 24132057 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light + placebo capsule
Number of subjects: 0
Study 24132057 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim light (placebo) + melatonin capsule
Number of subjects: 0
Study 24132057 — intervention group
Group type: COMPARATOR
Intervention: Dim light (placebo) + placebo capsule
Number of subjects: 0
Study 24132057 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 24132057 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined bright light + melatonin treatment
Number of subjects: 0
Study 21142615 — intervention group
Group type: EXPERIMENTAL
Intervention: PIO + SU
Number of subjects: 2388
Study 21142615 — intervention group
Group type: EXPERIMENTAL
Intervention: PIO + MET
Number of subjects: 2388
Study 21142615 — intervention group
Group type: COMPARATOR
Intervention: SU + MET
Number of subjects: 2388
Study 19175712 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafutidine 10 mg twice daily for 12 weeks plus gargling with azulene sulfonate sodium (ASS)
Number of subjects: 71
Study 19175712 — intervention group
Group type: COMPARATOR
Intervention: Previous H2RAs plus ASS gargling (control group)
Number of subjects: 71
Study 17069835 — intervention group
Group type: EXPERIMENTAL
Intervention: New ST-segment elevation of 0.1 mV or greater
Number of subjects: 506
Study 15482043 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused preventive intervention combined with academic tutoring
Number of subjects: 424
Study 15482043 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 424
Study 16394041 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based lubricant (0.5 mL contaminated specimen)
Number of subjects: 200
Study 16394041 — intervention group
Group type: COMPARATOR
Intervention: Control (non-contaminated specimen)
Number of subjects: 200
Study 10393617 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing physical activity program
Number of subjects: 9
Study 10393617 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9
Study 9171503 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS-Empress inlays and onlays
Number of subjects: 36
Study 1759375 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy with psychotherapy
Number of subjects: 0
Study 1759375 — intervention group
Group type: COMPARATOR
Intervention: Balneotherapy without psychotherapy
Number of subjects: 0
Study 1759375 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment with psychotherapy
Number of subjects: 0
Study 1759375 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment without psychotherapy
Number of subjects: 0
Study 6176753 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (Velban, Bleomycin, Cis-Platinum, Ifosfamid)
Number of subjects: 25
Study 6176753 — intervention group
Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 25
Study 31549922 — intervention group
Group type: COMPARATOR
Intervention: Traditional CHO replacement (TRAD)
Number of subjects: 8
Study 31549922 — intervention group
Group type: EXPERIMENTAL
Intervention: Train-high sleep-low (THSL)
Number of subjects: 8
Study 29396016 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 100
Study 29396016 — intervention group
Group type: COMPARATOR
Intervention: Placebo (routine care only)
Number of subjects: 100
Study 27485852 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester Practice Computer Risk Score (LPCRS)
Number of subjects: 577
Study 27485852 — intervention group
Group type: COMPARATOR
Intervention: Leicester Self‐Assessment Score (LSAS)
Number of subjects: 577
Study 27485852 — intervention group
Group type: EXPERIMENTAL
Intervention: LPCRS
Number of subjects: 577
Study 27485852 — intervention group
Group type: COMPARATOR
Intervention: LSAS
Number of subjects: 577
Study 25153429 — intervention group
Group type: EXPERIMENTAL
Intervention: e-PBL program consisting of eight tutorials
Number of subjects: 32
Study 25153429 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 22210451 — intervention group
Group type: EXPERIMENTAL
Intervention: Glazing techniques (five glazing ceramics applied and fired)
Number of subjects: 110
Study 22210451 — intervention group
Group type: COMPARATOR
Intervention: Resin based cement alone (Control Group A)
Number of subjects: 110
Study 22210451 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage regimes (wet storage vs thermocycling)
Number of subjects: 110
Study 20107305 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0
Study 20107305 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 17413907 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 0 ng/ml
Number of subjects: 45
Study 17413907 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 2 ng/ml
Number of subjects: 45
Study 17413907 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 4 ng/ml
Number of subjects: 45
Study 16117181 — intervention group
Group type: EXPERIMENTAL
Intervention: Energising drink (caffeine and glucose)
Number of subjects: 40
Study 16117181 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 40
Study 12118653 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal factor infertility
Number of subjects: 749
Study 12118653 — intervention group
Group type: EXPERIMENTAL
Intervention: Male factor infertility
Number of subjects: 749
Study 12118653 — intervention group
Group type: EXPERIMENTAL
Intervention: Anovulation
Number of subjects: 749
Study 12118653 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometriosis
Number of subjects: 749
Study 12118653 — intervention group
Group type: EXPERIMENTAL
Intervention: Unexplained infertility
Number of subjects: 749
Study 10459691 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylcobalamin (Met-12) - large dosage
Number of subjects: 0
Study 10459691 — intervention group
Group type: COMPARATOR
Intervention: Control group - small dosage
Number of subjects: 0
Study 7778622 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (0.5 mg, three doses 6 hours apart)
Number of subjects: 99
Study 7778622 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol cream (4 mg, three doses 6 hours apart)
Number of subjects: 99
Study 7778622 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (at induction per protocol with an infusion pump)
Number of subjects: 99
Study 2202480 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 55
Study 2202480 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 55
Study 31382005 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) during walking for 1 hour on a supervised treadmill
Number of subjects: 168
Study 31382005 — intervention group
Group type: COMPARATOR
Intervention: Control group (nondiabetic patients)
Number of subjects: 168
Study 28881480 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomineralized second primary molars (HSPM)
Number of subjects: 623
Study 28881480 — intervention group
Group type: EXPERIMENTAL
Intervention: HSPM
Number of subjects: 623
Study 27018069 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 61
Study 27018069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 24503408 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/mL posterior subtenon injection of nanoparticle carboplatin
Number of subjects: 6
Study 22215165 — intervention group
Group type: EXPERIMENTAL
Intervention: Low protein diet (5% of energy from protein)
Number of subjects: 25
Study 22215165 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal protein diet (15% of energy from protein)
Number of subjects: 25
Study 22215165 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (25% of energy from protein)
Number of subjects: 25
Study 20300029 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exposure for 2 nights
Number of subjects: 13
Study 20300029 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exposure for 2 days + nights
Number of subjects: 13
Study 20300029 — intervention group
Group type: COMPARATOR
Intervention: Control session (1 week before or after altitude session)
Number of subjects: 13
Study 20300029 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exposure
Number of subjects: 13
Study 17214524 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Le Fort I osteotomy
Number of subjects: 22
Study 17214524 — intervention group
Group type: COMPARATOR
Intervention: Le Fort I distraction
Number of subjects: 22
Study 15870641 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable intensity (VAR) Spinning protocol
Number of subjects: 15
Study 15870641 — intervention group
Group type: COMPARATOR
Intervention: Constant intensity (CON)
Number of subjects: 15
Study 12000487 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 16
Study 12000487 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone
Number of subjects: 16
Study 9802848 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 20
Study 9802848 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 20
Study 9098274 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment after trabeculectomy
Number of subjects: 35
Study 9098274 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroid treatment after trabeculectomy
Number of subjects: 35
Study 2487533 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 44
Study 2487533 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 44
Study 2487533 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin with cholestyramine
Number of subjects: 44
Study 2487533 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin with bezafibrate
Number of subjects: 44
Study 648206 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 25
Study 648206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31788828 — intervention group
Group type: EXPERIMENTAL
Intervention: Field-directed thulium laser (TL)
Number of subjects: 12
Study 31788828 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination thulium laser and photodynamic therapy (TL-PDT)
Number of subjects: 12
Study 31788828 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser (TL)
Number of subjects: 12
Study 31788828 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 12
Study 31788828 — intervention group
Group type: COMPARATOR
Intervention: Lesion-directed curettage control
Number of subjects: 12
Study 30978265 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant therapy
Number of subjects: 32
Study 30978265 — intervention group
Group type: COMPARATOR
Intervention: Standard antiemetic therapy
Number of subjects: 32
Study 28449280 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 150 μg.kg‐1
Number of subjects: 300
Study 28449280 — intervention group
Group type: EXPERIMENTAL
Intervention: droperidol 10 μg.kg‐1
Number of subjects: 300
Study 28449280 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 300
Study 25577522 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-guided core needle biopsy using DCE targeting
Number of subjects: 53
Study 24084214 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (angiotensin receptor blocker)
Number of subjects: 114
Study 24084214 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (beta-adrenergic receptor blocker)
Number of subjects: 114
Study 24084214 — intervention group
Group type: COMPARATOR
Intervention: Normotensive group
Number of subjects: 114
Study 24084214 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive heart disease group
Number of subjects: 114
Study 20863418 — intervention group
Group type: EXPERIMENTAL
Intervention: SCGOS/LCFOS/AOS
Number of subjects: 113
Study 20863418 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 113
Study 20863418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SCGOS/LCFOS/AOS and placebo)
Number of subjects: 113
Study 20863418 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BW
Number of subjects: 113
Study 20863418 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breast milk feeding
Number of subjects: 113
Study 20863418 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed breast milk/formula feeding
Number of subjects: 113
Study 18197403 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg twice daily)
Number of subjects: 12
Study 18197403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16292089 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dose of omeprazole (20 mg; 60 mg/3 days)
Number of subjects: 142
Study 16292089 — intervention group
Group type: COMPARATOR
Intervention: High dose of omeprazole (80 mg bolus + 8 mg/h; 652 mg/3 days)
Number of subjects: 142
Study 16292089 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dose of omeprazole
Number of subjects: 142
Study 16292089 — intervention group
Group type: COMPARATOR
Intervention: High dose of omeprazole
Number of subjects: 142
Study 12465390 — intervention group
Group type: EXPERIMENTAL
Intervention: HCFU 300 mg/day orally from day 14 for a year, plus intravenous mitomycin C (MMC) 6 mg/m2 on day 0 and 7 after surgery.
Number of subjects: 326
Study 12465390 — intervention group
Group type: COMPARATOR
Intervention: Intravenous mitomycin C (MMC) 6 mg/m2 on day 0 and 7 after surgery.
Number of subjects: 326
Study 10622542 — intervention group
Group type: EXPERIMENTAL
Intervention: No-touch technique (SV harvested with surrounding tissue, left in situ, covered with saline-soaked compress, stored in heparinized blood)
Number of subjects: 0
Study 10622542 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (adventitial stripping of the vein, manual distention, storing in saline)
Number of subjects: 0
Study 10622542 — intervention group
Group type: COMPARATOR
Intervention: Intermediate technique (adventitial stripping, left in situ, covered with papaverine-soaked compress, stored in heparinized blood)
Number of subjects: 0
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg 8‐MOP
Number of subjects: 18
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg 8‐MOP
Number of subjects: 18
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg 8‐MOP
Number of subjects: 18
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg 8‐MOP added to 300 ml platelet concentrate
Number of subjects: 18
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 7.5 mg 8‐MOP over 60 min
Number of subjects: 18
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of 8‐MOP
Number of subjects: 18
Study 8554937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic models
Number of subjects: 18
Study 1838256 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% ketoconazole cream (Nizoral)
Number of subjects: 60
Study 1838256 — intervention group
Group type: COMPARATOR
Intervention: Bland cream (control)
Number of subjects: 60
Study 6117584 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo injection (holiday group)
Number of subjects: 31
Study 6117584 — intervention group
Group type: COMPARATOR
Intervention: Regular medication (control group)
Number of subjects: 31
Study 29550235 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Limited Formula (ELF), 10 mL of formula after each breastfeeding until copious maternal milk production
Number of subjects: 164
Study 29550235 — intervention group
Group type: COMPARATOR
Intervention: Control group (exclusive breastfeeding)
Number of subjects: 164
Study 29550235 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Limited Formula (ELF)
Number of subjects: 164
Study 28793919 — intervention group
Group type: EXPERIMENTAL
Intervention: Family based intervention program including supervised exercise (3 days/week, 90 min per session)
Number of subjects: 84
Study 28793919 — intervention group
Group type: COMPARATOR
Intervention: Family based lifestyle education and psycho-educational program (2 days/month)
Number of subjects: 84
Study 26349843 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (25 mg/ml)
Number of subjects: 30
Study 26349843 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study 24016502 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical therapy (IMT)
Number of subjects: 1605
Study 24016502 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1605
Study 24016502 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 1605
Study 21099666 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate switch to etravirine (ETR)
Number of subjects: 38
Study 21099666 — intervention group
Group type: COMPARATOR
Intervention: Delayed switch (placebo)
Number of subjects: 38
Study 21099666 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (both arms)
Number of subjects: 38
Study 18236463 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose beta interferon-1a
Number of subjects: 28
Study 17022783 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-fibre electromyography (SFEMG) with monopolar needle electrode (MNPE)
Number of subjects: 37
Study 17022783 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-fibre electromyography (SFEMG) with single-fibre electrode (SFE)
Number of subjects: 37
Study 17022783 — intervention group
Group type: COMPARATOR
Intervention: Repetitive nerve stimulation (RNS) test
Number of subjects: 37
Study 17022783 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-fibre electromyography (SFEMG) with SFE
Number of subjects: 37
Study 17022783 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-fibre electromyography (SFEMG) with MNPE
Number of subjects: 37
Study 15265847 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin, 20 to 40 mg/d
Number of subjects: 214
Study 15265847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 15265847 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 214
Study 11084540 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous fetal pulse oximetry combined with electronic fetal monitoring (study group)
Number of subjects: 1010